Overview

Nefazodone in the Treatment of Social Phobia

Status:
Completed
Trial end date:
2000-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of nefazadone in patients with social anxiety disorder (SAD).
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Collaborator:
Bristol-Myers Squibb
Treatments:
Nefazodone